Although in this regard no data was found for HPV 39, it is indicated that the E-G350 variant of HPV 16 had 4–fivefold higher risk for cancer development among Swedish women with HLA-B*44, HLA-B*51, or HLA-B*57 alleles [25]. Here, HLA-B is linked to cancer.